Bourne Steven A. 4
4 · Clarus Therapeutics Holdings, Inc. · Filed Dec 14, 2021
Insider Transaction Report
Form 4
Bourne Steven A.
Chief Administrative Officer
Transactions
- Award
Common Stock
2021-12-11+29,000→ 30,305 total - Award
Stock Option (Right to Buy)
2021-12-11+72,500→ 72,500 totalExercise: $4.78Exp: 2031-12-10→ Common Stock (72,500 underlying)
Footnotes (2)
- [F1]The Reporting Person was granted a Restricted Stock Unit under the Issuer's 2021 Stock Option and Incentive Plan (the "2021 Plan") for 29,000 shares on 12/11/2021, of which 25% vest on 9/9/2022, and the remaining shares vest in 36 equal monthly installments thereafter subject to the Reporting Person continuing to have a service relationship as of each such vesting date.
- [F2]These options were granted under the 2021 Plan and vest (i) 25% on 9/9/2022 and (ii) with the remainder vesting in 36 equal monthly installments thereafter subject to the Reporting Person continuing to have a service relationship as of each such vesting date.